Guardant Health, Inc.
GH
$46.17
$1.984.48%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 14.06% | 0.82% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 14.06% | 0.82% | |||
| Cost of Revenue | 8.67% | -3.70% | |||
| Gross Profit | 17.19% | 3.64% | |||
| SG&A Expenses | 12.49% | -4.21% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.72% | -4.42% | |||
| Operating Income | 3.95% | 12.76% | |||
| Income Before Tax | -5.26% | 13.98% | |||
| Income Tax Expenses | -86.90% | -59.50% | |||
| Earnings from Continuing Operations | -4.98% | 14.28% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -4.98% | 14.28% | |||
| EBIT | 3.95% | 12.76% | |||
| EBITDA | 4.16% | 13.72% | |||
| EPS Basic | -4.78% | 14.36% | |||
| Normalized Basic EPS | -11.24% | 21.58% | |||
| EPS Diluted | -4.78% | 14.36% | |||
| Normalized Diluted EPS | -11.24% | 21.58% | |||
| Average Basic Shares Outstanding | 0.20% | 0.09% | |||
| Average Diluted Shares Outstanding | 0.20% | 0.09% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||